Whether you treat patients with transplantable disorders or perform hematopoietic transplantation, this CME-certified program provides an efficient way to hear the latest review in allogeneic transplantation today. In this session, you will learn about advances in HLA typing including clinical and technology innovations.
Dennis L. Confer, M.D.
Chief Medical Officer
National Marrow Donor Program
Clinical Professor of Medicine
University of Minnesota
- Distinguish between low-, intermediate-, and high-resolution HLA DNA typing
- Describe issues in HLA typing that complicate finding an HLA-matched donor
- Describe the use of haplotypes in HLA matching and matching marrow donors to patients
This activity is intended for physicians and other healthcare providers who treat patients with hematological malignancies in need of allogeneic transplantation.
The goal of this activity is to provide physicians and other healthcare providers with information on the new research that defines when transplantation should be considered, whether the outcomes are different between related and unrelated donors, the current state of HLA matching, and insight into the future of transplantation medicine.
If you have any questions regarding this program, call Renee Ryan at (800) 526-7809 ext. 8430, or e-mail firstname.lastname@example.org